Optiver Holding B.V. »

Galectin Therapeutics shares owned by Optiver Holding B.V.

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Optiver Holding B.V. from 13F filings

Historical chart of Optiver Holding B.V. investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by Optiver Holding B.V. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by Optiver Holding B.V.

Quarter filed Position value Share count Share price at filing
2025-09-30 $75 18 4.22

More positions owned by Optiver Holding B.V.

Spdr S&p 500 Etf Tr Tr Unit Put Option
Spdr S&p 500 Etf Tr Tr Unit Call Option
Invesco Qqq Tr Unit Ser 1 Put Option
Invesco Qqq Tr Unit Ser 1 Call Option
Tesla Motors Inc cmn Call Option
Spdr Gold Tr Gold Shs Call Option
Nvidia Corp option Put Option
Tesla Motors Inc cmn Put Option
Spdr Gold Tr Gold Shs Put Option
Nvidia Corp option Call Option
Ishares Tr Msci Eafe Etf Put Option
On Semiconductor Corporation Put Option
Ishares Tr Msci Eafe Etf Call Option
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Dow Jones Indl Average Ut Ser 1 Put Option

View all positions for Optiver Holding B.V.

Top funds holding Galectin Therapeutics

Vanguard Group
Advisor Group Holdings
BlackRock
Geode Capital Management
Susquehanna International
Marshall Wace
Sontag Advisory
LPL Financial
Geneos Wealth Management
Commonwealth Equity Services
Vivaldi Capital Management
State Street Corporation
Morgan Stanley
Retirement Guys Formula
Sovran Advisors

View all funds holding Galectin Therapeutics